Osivax Partners with CEPI to Advance T-cell Immunity using World-First Adjuvant Library Access to CEPI’s Adjuvant Library to assess dose-sparing potential of adjuvanted formulations of OVX836 vaccine in flu pandemic settings Potential to maximize vaccine supply and broaden global access in emergencies, while maintaining a non-adjuvanted OVX836 core development path Lyon, France and Liège, Belgium – …